Years after National Enquirer's Trump deal, the tabloid is limping badly
Time:2024-04-26 02:13:43 Source:businessViews(143)
NEW YORK (AP) — Catch and kill. Checkbook journalism. Secret deals. Friends helping friends.
Even by National Enquirer standards, testimony by its former publisher David Pecker at Donald Trump’s hush money trial this week has revealed an astonishing level of corruption at America’s best-known tabloid and may one day be seen as the moment it effectively died.
“It just has zero credibility,” said Lachlan Cartwright, executive editor of the Enquirer from 2014 to 2017. “Whatever sort of credibility it had was totally damaged by what happened in court this week.”
On Thursday, Pecker was back on the witness stand to tell more about the arrangement he made to boost Trump’s presidential candidacy in 2016, tear down his rivals and silence any revelations that may have damaged him.
THE ENQUIRER HELPED FUEL THE RISE OF TABLOID CULTURE
However its stories danced on the edge of credulity, the Enquirer was a cultural fixture, in large part because of genius marketing. As many Americans moved to the suburbs in the 1960s, the tabloid staked its place on racks at supermarket checkout lines, where people could see headlines about UFO abductions or medical miracles while waiting for their milk and bread to be bagged.
Previous:Pakistan wins toss, elects to field against NZ in 4th T20
Next:Malaria is still killing people in Kenya, but a vaccine and local drug production may help
You may also like
- Naomi Watts, 55, proves she's in the best shape of her life as she flexes her eye
- Two homes, five vehicles, $80,000 seized in police operation
- Boy, 6, reported missing in south Auckland found safe
- Russia arrests suspected attackers after mass shooting kills 93 at concert
- Olivia Dunne calls for boyfriend Paul Skenes to get his Pittsburgh Pirates MLB debut
- Wellington water: Threat of further restrictions recedes
- Person dies after crash in Waipā, Waikato
- All Newshub operations to be shut down, 250 jobs to go
- Malaria is still killing people in Kenya, but a vaccine and local drug production may help